Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non-Small-Cell Lung Cancer in the Community Setting
By Marcus A. Neubauer. Study results suggest that treating non-small-cell lung cancer patients per these guidelines is a cost-effective strategy for delivering care.
